TNO launches Peregrion to boost market impact of its technology that accelerates medicine development
TNO spin-off Peregrion brings science to the marketplace
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Mar 24
TNO spin-off Peregrion brings science to the marketplace
25 Mar 24
The approval was based on the findings from the confirmatory Phase 3 MIRASOL trial in which Elahere treatment…
25 Mar 24
The analyses revealed that Rexulti was linked to reductions in both overall neuropsychiatric symptoms and agitation symptoms when…
25 Mar 24
The label expansions are for the prevention of heart attacks and cardiovascular procedures in primary as well as…
25 Mar 24
eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the first…
25 Mar 24
Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver Diseases
25 Mar 24
AIDS Healthcare Foundation (AHF) country teams, which have prioritized screening for TB in clinics—along with preventing and treating…
25 Mar 24
The team are seeking to create ‘LungVax’, the world’s first vaccine to prevent lung cancer in people with…
22 Mar 24
LENZ Therapeutics to debut on Nasdaq under the ticker symbol “LENZ” as a publicly traded company advancing late…
15 Mar 24
The accelerated approval was based on the findings from the ongoing Phase 3 MAESTRO-NASH trial in which Rezdiffra…